Organ and tissue growth concerns Because IGF-1 signaling affects cellular growth and proliferation throughout the body and not exclusively in skeletal muscle, there is concern that long-term use of IGF-1 could result in increased growth of other tissues/organs in the body
dedicating the time to sift through dozens of supplements that all make the same claims is no simple task
One such class of medications is GLP-1 receptor agonists, commonly prescribed for type 2 diabetes and weight management
The 0.5 ml syringe (50 units total) is the mid-range option
Accordingly, plants, bacteria and lower eukaryotes express only CHAC2, while higher eukaryotes also express CHAC1 (Kaur et al., 2017)
Some patients report reduced hunger and earlier satiety within the first week of GLP-1 treatment, though individual response varies considerably